Considerations To Know About nembutal drug
Considerations To Know About nembutal drug
Blog Article
pentobarbital will lower the level or influence of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lower the extent or result of conivaptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital raises toxicity of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. CYP3A4 inducers may possibly increase the metabolism of ifosfamide to its Lively alkylating metabolites.
Training caution when a barbiturate is administered to the nursing lady; compact quantities of barbiturates are excreted inside the milk
pentobarbital will lessen the level or impact of irinotecan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
Contraindicated. Coadministration of doravirine with a solid CYP3A inducer may possibly minimize doravirine plasma concentrations and/or effects. Likely for lack of virologic response and attainable resistance to doravirine.
With therapeutic doses of TCAs, barbiturates improve metabolism and reduce blood concentrations of TCAs.
pentobarbital will lessen the extent or effect of pazopanib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will reduce the extent or effect of etonogestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will reduce the extent or impact of estradiol vaginal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the level or outcome of atazanavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Significance Not known.
pentobarbital will lessen the extent or impact of ondansetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. No dosage adjustment for ondansetron is suggested for patients on these drugs.
pentobarbital will minimize the level or effect of rolapitant by influencing hepatic/intestinal get more info enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Prolonged-term coadministration of potent CYP3A4 inducers with rolapitant may possibly substantially lower rolapitant efficacy.
Reserve concomitant prescribing of these drugs in clients for whom other treatment possibilities are inadequate. Limit dosages and durations to your minimum necessary. Watch intently for signs of respiratory depression and sedation.